Robert S. Jansen
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- Pharmacology top 5%
Papers in
-
- Biochemical and Molecular Research 9
-
- Tuberculosis Research and Epidemiology 10
- HIV/AIDS drug development and treatment 9
- Co-authors
- Jos H. Beijnen (23 shared papers)Hilde Rosing (18 shared papers)Jan H.M. Schellens (19 shared papers)Koen van de Wetering (8 shared papers)Piet Borst (5 shared papers)Kyu Y. Rhee (13 shared papers)Alwin D. R. Huitema (7 shared papers)Sunny Mahakena (4 shared papers)
- Journals
- Clinical Cancer Research (5 papers)Nature Communications (5 papers)Environmental Microbiology (3 papers)Analytical and Bioanalytical Chemistry (2 papers)The ISME Journal (2 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Robert S. Jansen
59 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 140
- Oncology 548
- Pharmacology 158
- Infectious Diseases 323
- Nephrology 117
- Molecular Medicine 81
Countries citing papers authored by Robert S. Jansen
This map shows the geographic impact of Robert S. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Jansen more than expected).
Fields of papers citing papers by Robert S. Jansen
This network shows the impact of papers produced by Robert S. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Jansen. The network helps show where Robert S. Jansen may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert S. Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 225 | |
| 2 | 2013 | 195 | |
| 3 | 2015 | 151 | |
| 4 | 2006 | 107 | |
| 5 | 2015 | 95 | |
| 6 | 2018 | 80 | |
| 7 | 2006 | 76 | |
| 8 | 2004 | 71 | |
| 9 | 2009 | 63 | |
| 10 | 2008 | 60 | |
| 11 | 2008 | 57 | |
| 12 | 2020 | 55 | |
| 13 | 2015 | 52 | |
| 14 | 2006 | 52 | |
| 15 | 2023 | 50 | |
| 16 | 2020 | 48 | |
| 17 | 2020 | 48 | |
| 18 | 2011 | 41 | |
| 19 | 2009 | 39 | |
| 20 | 2017 | 38 |
About Robert S. Jansen
Robert S. Jansen is a scholar working on Molecular Biology, Infectious Diseases, Oncology, Epidemiology and Pharmacology, having authored 64 papers that have together received 2.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (10 papers), Drug Transport and Resistance Mechanisms (10 papers), Biochemical and Molecular Research (9 papers), HIV/AIDS drug development and treatment (9 papers), Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Antibiotic Resistance in Bacteria (6 papers). The work is most often cited by research in Oncology (548 citations), Pharmacology (158 citations), Infectious Diseases (323 citations), Nephrology (117 citations) and Molecular Medicine (81 citations). Robert S. Jansen has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jos H. Beijnen, Hilde Rosing, Jan H.M. Schellens, Koen van de Wetering, Piet Borst, Kyu Y. Rhee, Alwin D. R. Huitema, Sunny Mahakena, Arthur A. Bergen and Marcel de Haas. Their work appears in journals such as Clinical Cancer Research, Nature Communications, Environmental Microbiology, Analytical and Bioanalytical Chemistry and The ISME Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.